Page last updated: 2024-10-21

2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine and Glioma

2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine has been researched along with Glioma in 1 studies

2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine: a selective inhibitor of nitric oxide synthase; structure given in first source

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oyoshi, T1
Nomoto, M1
Hirano, H1
Kuratsu, J1

Other Studies

1 other study available for 2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine and Glioma

ArticleYear
Pathodynamics of nitric oxide production within implanted glioma studied with an in vivo microdialysis technique and immunohistochemistry.
    Journal of pharmacological sciences, 2003, Volume: 91, Issue:1

    Topics: Animals; Brain Neoplasms; Enzyme Inhibitors; Glioma; Half-Life; Immunohistochemistry; Male; Microdia

2003